BLAUVELT, A.; WARREN, R.; REICH, K.; BROCK, F.; FIERENS, F.; CIARAVINO, V.; LEBWOHL, M. Durability of DLQI Improvements Among Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 6, p. s80, 2020. DOI: 10.25251/skin.4.supp.80. Disponível em: https://dermsquared.com/skin/article/view/1113. Acesso em: 20 sep. 2024.